By Christopher Robison | Updated Aug 30, 2022
Kingdom Monera represents the collective group of all prokaryotic (non‑nucleated) organisms—tiny, single‑cell life forms that have colonized every corner of our planet. Their sheer numbers make them the most successful organisms on Earth.
While the term "Monera" is historically used interchangeably with "bacteria," modern phylogenetic studies reveal that Monera is not a monophyletic group; it spans multiple branches of the tree of life. Despite this, discussing prokaryotes as a unified entity remains valuable due to their shared structural and functional traits.
In 1977, microbiologist Carl Woese argued that prokaryotes cannot be grouped into a single kingdom. Subsequent research confirmed an ancient split within Monera, dividing it into two distinct domains: Archaea and Bacteria.
Some scientists, like Thomas Cavalier‑Smith of Oxford University, prefer to retain a single grouping—prokaryotes—under the broader kingdom Prokaryota, subdivided into the two sub‑kingdoms. Typical bacteria (eubacteria) include notable human pathogens such as Yersinia pestis, the agent of bubonic plague, while archaea often thrive in extreme environments, exemplified by Thermoplasma volcanium, which inhabits sulfuric hot springs.
Prokaryotes inhabit every ecological niche, from the upper atmosphere to the ocean floor and deep within Earth's crust. Microbiologist William Whitman estimates there are roughly 5×10³⁰ moneran cells worldwide—a staggering 5 followed by 30 zeros.
Collectively, the mass of bacteria rivals that of all other life on Earth combined. An average human harbors ten times more prokaryotic cells than human cells, yet these microorganisms constitute only about 2 % of body mass.
Bacterial infections arise when bacterial populations outpace the host's defenses, leading to symptoms that vary with infection site, severity, and bacterial species. For example, Streptococcus pneumoniae can cause either sinusitis or pneumonia, depending on where it colonizes.
Antibiotics target differences between human and bacterial cells, inhibiting bacterial division or vital processes. When bacteria acquire resistance—often through mutations or horizontal gene transfer—they become less susceptible to these drugs.
Monerans lack a nucleus but possess other internal and external structures. Most have a rigid cell wall composed of cross‑linked peptidoglycan that protects against environmental stresses.
The bacterial chromosome, or nucleoid, houses DNA and is anchored to the cell membrane. Plasmids—smaller circular DNA loops—carry accessory genes. Ribosomes translate DNA‑encoded messages into proteins.
Motility is achieved via flagella, which act as molecular propellers, or alternative mechanisms such as the Listeria strategy, which hijacks host cell machinery to move along protein filaments.
Monerans can exchange genetic material not only vertically but also horizontally, incorporating foreign DNA from distant relatives or the environment. This mechanism fuels rapid adaptation and evolution across prokaryotic populations.
Cyanobacteria—photosynthetic prokaryotes—were pivotal in transforming Earth’s early atmosphere. By converting carbon dioxide into oxygen, they initiated the rise of atmospheric oxygen about 2.45 billion years ago. Today, both photosynthetic eukaryotes and prokaryotes maintain the balance between CO₂ and O₂.
